Jade Biosciences, Inc., a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced the appointment of Brad Dahms as Chief Financial Officer.
CFO at Jade Biosciences
July 1, 2025
Jade Biosciences, Inc., a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced the appointment of Brad Dahms as Chief Financial Officer.